Conversely, we found a downregulation of VLDLR, whose genetic or epigenetic silencing contributes to gastric carcinogenesis (70), CYP27A1, which induces T cell dysfunction, thus promoting breast cancer progression (71) and CCL2, downregulated in diffuse gastric cancer primarily in advanced stages (72). The gene discussed is CCL2; the disease is breast carcinoma.